Literature DB >> 886358

Fatal measles encephalopathy with retinopathy during cytotoxic chemotherapy.

M Haltia, A Paetau, A Vaheri, H Erkkilä, M Donner, K Kaakinen, T Holmström.   

Abstract

A 14-year-old boy receiving post-operative cytotoxic chemotherapy for a testicular rhabdomyosarcoma developed a fatal encephalopathy associated with retinal changes 2 months after an episode of acute measles. Post-mortem histological examination showed intranuclear inclusion bodies in the neurons and glial cells, but inflammatory cell infiltrations were absent. Electron-microscopic and immunofluorescent studies revealed intracellular masses of paramyxovirus nucleocapsid-like structures, which had the morphological and antigenic properties of measles virus. Recent reports have emphasized the possibility of occurrence of a similar encephalopathy in treated childhood leukemia. It is evident, however, that this potentially fatal complication must be borne in mind when measles is contracted during any form of cytotoxic treatment or immunosuppression. Retinal changes may be of value for the diagnosis during life. We propose the designation "measles encephalopathy during immunosuppression" (MEI) for this condition.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 886358     DOI: 10.1016/0022-510x(77)90015-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Measles retinopathy during immunosuppression.

Authors:  M Haltia; A Tarkkanen; A Vaheri; A Paetau; K Kaakinen; H Erkkilä
Journal:  Br J Ophthalmol       Date:  1978-06       Impact factor: 4.638

2.  Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia.

Authors:  I Hughes; M E Jenney; R W Newton; D J Morris; P E Klapper
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.